ImmBio is Drug Discovery in United Kingdom that focus on normal immune responses business. Founded in 1999. They cover business area such as developer, vaccine, treatment, infectious disease, cancer, bacterial infection, mimic normal immune response, pathogen, multi-protein complex, elicit priming, health care provider, immunity, dendritic cell.
1999
( 25 years old in 2024 )
Normal Immune Responses
-
Babraham Research Campus
Babraham
Cambridge CB22 3AT
England, United Kingdom
Private
developervaccinetreatmentinfectious diseasecancerbacterial infectionmimic normal immune responsepathogenmulti-protein complexelicit priminghealth care providerimmunitydendritic cell
* We use standard office opening hours in near ImmBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ImmBio is Drug Discovery business from United Kingdom that founded in 1999 (25 years old in 2024), ImmBio business is focusing on Normal Immune Responses.
ImmBio headquarter office and corporate office address is located in Babraham Research Campus Babraham Cambridge CB22 3AT England, United Kingdom.
ImmBio was founded in United Kingdom.
In 2024, ImmBio is currently focus on normal immune responses sector.
Above is snippet of Google Trends for "normal immune responses" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ImmBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
